Key Aspects of Medical Practice in Patients With Haemophilia A (KAPPA)

Lund University

Status: Withdrawn

Conditions: Joint Disease

Treatments: Biological: Factor VIII replacement

Study type: Observational

Funder types: Other

Identifiers

NCT02996942

2012/118

Details and patient eligibility

About

The KAPPa project has the aim to create an international database in which information about clinical features, therapeutic management, burden of illness and costs of severe and moderate haemophilia A patients from different countries and sites is collected. The aim of this project is to analyse the influence of such different characteristics on medical, psychosocial and economic outcomes in patients over the long-term.

Full description

1000 patients with hemophilia A will be enrolled using a webbased registry. Key quality factors that will be registered are : hemophilia joint Health score (HJHS), annual bleed rate, quality of Life (EQ5D), as well as dosing of replacement therapy.

Sex: All

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria: or forms.

• severe haemophilia A (factor VIII<1%)
• moderate (factor VIII<5%)
• signed informed consent

Exclusion Criteria:

• Not fullfilling inclusion criteria

Trial design

0 participants in 1 patient group

Replacement therapy

Description:

Hemophilia A receiving replacement therapy (prophylaxis or on demand)

Treatment:

Biological: Factor VIII replacement